Re: integrated parent-metabolite PK model from sequential iv and oral doses of parent drug

From: Leonid Gibiansky Date: February 17, 2014 technical Source: mail-archive.com
Kok-Yong The code is too complicated (just a technical comment) and in fact is equivalent to ..... F1 = THETA(6)*EXP(IIVF1) ..... S2 = V2 ... IF (TIME.GT.4) THEN S2 = V2/F1 ... as all the other parameters are identical in both parts of the IF() block. As is, the code allows F1 > 1 that would be unusual. If you would like to keep individual F1 values below 1 it is better to code it as F1 = 1/(1+EXP(THETA(6)*EXP(IIVF1))) (where THETA(6) is allowed to be both positive and negative) Also, why do you have two dose records for each dose? Why FMET is fixed to 0.6, was it estimated? The main problem is S2 = V2/F1 part that is not mechanistic at all. What exactly was wrong without this part, were predicted metabolite concentrations too low or to high? Have you seen this work: http://tucson2008.go-acop.org/pdfs/51_gieschke.pdf that deals with a very similar problem? Note that the model in the poster above allows some part of the oral dose to bypass the parent compartment, and also it has an intermediate compartment (delay between parent and metabolite) which also can be helpful in fitting the data. Regards, Leonid -------------------------------------- Leonid Gibiansky, Ph.D. President, QuantPharm LLC web: www.quantpharm.com e-mail: LGibiansky at quantpharm.com tel: (301) 767 5566
Quoted reply history
On 2/17/2014 3:22 AM, Seng Kok Yong wrote: > Dear fellow NMusers, > > I'm trying to develop an integrated parent-metabolite PK model based on the plasma concentrations > obtained from 40 subjects after sequential iv and oral administrations of the parent drug. The iv > bolus was injected at time = 0 while the oral dose was administered at time = 4h. The most stable > model so far is a two-compartment model for the parent drug (with first-order absorption) linked to > a one-compartment metabolite model. However, in order to obtain reasonable parameter estimates and > adequate goodness-of-fit plots, I needed to specify a "switch" in rate constant values > and scaling factors at time = 4h (oral administration time), as defined in the control stream > below. Without, this "switch", there was a very poor match between the measured and > predicted metabolite concentration values. > > May I ask if my code below is correct for modelling the data at hand (assuming > the abovementioned structural model)? If not, would you be able to suggest > possible areas of model improvement? > > Thank you and best wishes, > Kok-Yong SENG, PhD > DSO National Laboratories > Singapore > ______________________ > > $PROB RUN# 1 parent-met data (nmol/L vs h) > $INPUT ID NTIM TIME DV AMT ORAL CMT EVID MDV > $DATA DATA.CSV IGNORE=C > > $SUBROUTINE ADVAN5 > > $MODEL > NCOMP=4 > COMP=(DEPOT) > COMP=(CENTRAL, DEFDOSE) > COMP=(METAB1) > COMP=(PERIPM) > > $PK > IIVCL = ETA(1) > IIVF1 = ETA(2) > IIVKA = ETA(3) > IIVCL1 = ETA(4) > IIVV3 = ETA(5) > KA = THETA(1)*EXP(IIVKA) > CL = THETA(2)*EXP(IIVCL) > V2 = THETA(3) > Q = THETA(4) > V4 = THETA(5) > F1 = THETA(6)*EXP(IIVF1) > > FMET = 0.6 > > CL1 = THETA(7)*EXP(IIVCL1) > V3 = THETA(8)*EXP(IIVV3) > > IF (TIME.LE.4) THEN > > S2 = V2 > S3 = V3 > K12 = KA > K20 = (1-FMET)*(CL/V2) > K23 = FMET*(CL/V2) > K24 = Q/V2 > K42 = Q/V4 > K30 = CL1/V3 > > ELSE > > S2 = V2/F1 > S3 = V3 > K12 = KA > K20 = (1-FMET)*((CL/F1)/(V2/F1)) > K23 = FMET*((CL/F1)/(V2/F1)) > K24 = (Q/F1)/(V2/F1) > K42 = (Q/F1)/(V4/F1) > K30 = CL1/V3 > > ENDIF > > $ERROR ;ONLY OBSERVATIONS) > > IF (AMT.GT.0) TDOS=TIME > TAD=TIME-TDOS > > IF (F.EQ.0) THEN > IPRED=0 > ELSE > IPRED=LOG(F) > ENDIF > IRES=DV-IPRED > > IF(CMT.EQ.2) W2 = SQRT(THETA(9)**2 ) > IF(CMT.EQ.3) W3 = SQRT(THETA(10)**2 ) > IF(CMT.EQ.2) IWRES=IRES/W2 > IF(CMT.EQ.3) IWRES=IRES/W3 > IF(CMT.EQ.2) Y = IPRED + (W2)*EPS(1) ; > IF(CMT.EQ.3) Y = IPRED + (W3)*EPS(2) > > $THETA > $OMEGA > $SIGMA > 1 FIX > 1 FIX > > $EST METHOD=1 INTER MAXEVAL=9999 PRINT=1 POSTHOC NOABORT MSFO=1.MSF SIGL=9 > NSIG=3 > $COV UNCONDITIONAL PRINT=E > > :::::DATA.csv::::: (for first two subjects) > C Data Desc: parent-met data (dose in nmoles; time in hr; conc in nmol/L) > > CID NTIM TIME DV AMT ORAL CMT EVID MDV > 101 0 0 0 2302.308 . 2 1 1 > 101 0 0 0 2302.308 . 2 1 1 > 101 0.25 0.25 5.430537181 . . 2 0 0 > 101 0.25 0.25 0.741358053 . . 3 0 0 > 101 0.5 0.5 4.799111134 . . 2 0 0 > 101 0.5 0.5 0.854669023 . . 3 0 0 > 101 0.75 0.75 4.55617397 . . 2 0 0 > 101 0.75 0.75 0.691490788 . . 3 0 0 > 101 1 1 4.106244674 . . 2 0 0 > 101 1 1 0.589508916 . . 3 0 0 > 101 1.5 1.5 3.822383616 . . 2 0 0 > 101 1.5 1.5 0.409972825 . . 3 0 0 > 101 2 2 3.652067835 . . 2 0 0 > 101 2 2 0.284763877 . . 3 0 0 > 101 2.5 2.5 3.346291176 . . 2 0 0 > 101 2.5 2.5 0.08938465 . . 3 0 0 > 101 3 3 3.121642304 . . 2 0 0 > 101 3 3 -0.090114893 . . 3 0 0 > 101 3.5 3.5 3.278754426 . . 2 0 0 > 101 3.5 3.5 -0.108362666 . . 3 0 0 > 101 4 4 . 4604.619 1 1 1 1 > 101 4 4 . 4604.619 1 1 1 1 > 101 4 4 3.44923847 . 1 2 0 0 > 101 4 4 -0.071713115 . 1 3 0 0 > 101 4.25 4.25 3.597385022 . 1 2 0 0 > 101 4.25 4.25 -0.048409056 . 1 3 0 0 > 101 4.5 4.5 3.716095668 . 1 2 0 0 > 101 4.5 4.5 1.175372119 . 1 3 0 0 > 101 4.75 4.75 4.154635181 . 1 2 0 0 > 101 4.75 4.75 2.212447576 . 1 3 0 0 > 101 5 5 4.08855346 . 1 2 0 0 > 101 5 5 2.253719503 . 1 3 0 0 > 101 5.5 5.5 3.726503911 . 1 2 0 0 > 101 5.5 5.5 1.86297201 . 1 3 0 0 > 101 6 6 3.52409438 . 1 2 0 0 > 101 6 6 1.48545147 . 1 3 0 0 > 101 7 7 -0.791943487 . 1 3 0 0 > 101 8 8 2.861295756 . 1 2 0 0 > 101 8 8 0.195365359 . 1 3 0 0 > 101 10 10 2.960551062 . 1 2 0 0 > 101 10 10 -0.709552271 . 1 3 0 0 > 101 12 12 2.164593204 . 1 2 0 0 > 101 12 12 -0.857712813 . 1 3 0 0
Feb 17, 2014 Seng Kok Yong integrated parent-metabolite PK model from sequential iv and oral doses of parent drug
Feb 17, 2014 Rob ter Heine RE: integrated parent-metabolite PK model from sequential iv and oral doses of parent drug
Feb 17, 2014 Leonid Gibiansky Re: integrated parent-metabolite PK model from sequential iv and oral doses of parent drug